News

  01/08/2024 | Technology

Bühler and NRGene Canada open North American Insect Center

– Bühler, the Swiss technology group, and NRGene Canada, a subsidiary of NRGene Technologies Ltd. (TASE: NRGN), an Israeli genomics company, celebrated the successful launch of the North American Insect Center (NAIC) on 30th July The inauguration event, held at NRGene Canada's facility in Saskatoon, marks a significant leap forward in the production and optimization of insect protein in North America. The NAIC is designed as a research and demonstration center where customers can evaluate the performance of Black Soldier Fly (BSF) varieties tailored to their specific by-product streams. The cutting-edge facility is also dedicated to supporting investors in evaluating the economic viability of larger plants before committing to full-scale investment. This innovative approach empowers businesses to make informed decisions, ensuring optimal efficiency and sustainability in protein production. The launch event featured a tour of the cutting-edge lab, showcasing the advanced capabilities of the NAIC. Attendees included Dr. Gil Ronen, CEO and Co-Founder of NRGene, Andreas Baumann, Head of Market Segment Insect Technology at Bühler, and Jeremy Harrison, Minister of Trade and Export Development. "Saskatchewan is continuing to attract innovative companies who are choosing to invest and grow their business in our province,” Harrison noted. “Our reputation as global leaders in agricultural and biotechnology is attracting record capital investment into the province. We’re very proud to see the North American Insect Center join a growing list of cutting-edge institutions here in the province. This facility will create new skilled jobs and further position Saskatchewan as a center for alternative protein production research and a leader in global food security.” Equipped with Bühler’s advanced Trial Rearing Unit (TRU), the NAIC simulates industrial conditions to optimize the growth of BSF larvae. NRGene’s expertise in genomics and phenotyping enables the development of high-performing BSF strains, driving significant advancements in the field. Initial trials have already shown remarkable results, highlighting the synergy between cutting-edge technology and genetic innovation. The center can also customize solutions for different kinds of waste, further enhancing its versatility and sustainability impact.

www.buhlergroup.com